Mahauad-Fernandez WD - Search Results

1

Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma.

Deutzmann A, Sullivan DK, Dhanasekaran R, Li W, Chen X, Tong L, Mahauad-Fernandez WD, Bell J, Mosley A, Koehler AN, Li Y, Felsher DW. Deutzmann A, et al. Among authors: mahauad fernandez wd. Nat Commun. 2024 Feb 1;15(1):963. doi: 10.1038/s41467-024-45128-y. Nat Commun. 2024. PMID: 38302473 Free PMC article.

2

The MYC oncogene - the grand orchestrator of cancer growth and immune evasion.

Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM, Felsher DW. Dhanasekaran R, et al. Among authors: mahauad fernandez wd. Nat Rev Clin Oncol. 2022 Jan;19(1):23-36. doi: 10.1038/s41571-021-00549-2. Epub 2021 Sep 10. Nat Rev Clin Oncol. 2022. PMID: 34508258 Free PMC article. Review.

3

Generation of a Tetracycline Regulated Mouse Model of MYC-Induced T-Cell Acute Lymphoblastic Leukemia.

Mahauad-Fernandez WD, Rakhra K, Felsher DW. Mahauad-Fernandez WD, et al. Methods Mol Biol. 2021;2318:297-312. doi: 10.1007/978-1-0716-1476-1_16. Methods Mol Biol. 2021. PMID: 34019298

4

The Myc and Ras Partnership in Cancer: Indistinguishable Alliance or Contextual Relationship?

Mahauad-Fernandez WD, Felsher DW. Mahauad-Fernandez WD, et al. Cancer Res. 2020 Sep 15;80(18):3799-3802. doi: 10.1158/0008-5472.CAN-20-0787. Epub 2020 Jul 30. Cancer Res. 2020. PMID: 32732221 Free PMC article.

5

Development and Characterization of the Shortest Anti-Adhesion Peptide Analogue of B49Mod1.

Lyu Y, Mahauad-Fernandez WD, Okeoma CM. Lyu Y, et al. Among authors: mahauad fernandez wd. Molecules. 2020 Mar 6;25(5):1188. doi: 10.3390/molecules25051188. Molecules. 2020. PMID: 32155736 Free PMC article.

6

BST-2 promotes survival in circulation and pulmonary metastatic seeding of breast cancer cells.

Mahauad-Fernandez WD, Naushad W, Panzner TD, Bashir A, Lal G, Okeoma CM. Mahauad-Fernandez WD, et al. Sci Rep. 2018 Dec 4;8(1):17608. doi: 10.1038/s41598-018-35710-y. Sci Rep. 2018. PMID: 30514852 Free PMC article.

7

B49, a BST-2-based peptide, inhibits adhesion and growth of breast cancer cells.

Mahauad-Fernandez WD, Okeoma CM. Mahauad-Fernandez WD, et al. Sci Rep. 2018 Mar 9;8(1):4305. doi: 10.1038/s41598-018-22364-z. Sci Rep. 2018. PMID: 29523843 Free PMC article.

8

Structural determinant of BST-2-mediated regulation of breast cancer cell motility: a role for cytoplasmic tail tyrosine residues.

Naushad W, Mahauad-Fernandez WD, Okeoma CM. Naushad W, et al. Among authors: mahauad fernandez wd. Oncotarget. 2017 Nov 29;8(66):110221-110233. doi: 10.18632/oncotarget.22753. eCollection 2017 Dec 15. Oncotarget. 2017. PMID: 29299143 Free PMC article.

9

Cysteine-linked dimerization of BST-2 confers anoikis resistance to breast cancer cells by negating proapoptotic activities to promote tumor cell survival and growth.

Mahauad-Fernandez WD, Okeoma CM. Mahauad-Fernandez WD, et al. Cell Death Dis. 2017 Mar 16;8(3):e2687. doi: 10.1038/cddis.2017.68. Cell Death Dis. 2017. PMID: 28300825 Free PMC article.

10

The role of BST-2/Tetherin in host protection and disease manifestation.

Mahauad-Fernandez WD, Okeoma CM. Mahauad-Fernandez WD, et al. Immun Inflamm Dis. 2015 Dec 7;4(1):4-23. doi: 10.1002/iid3.92. eCollection 2016 Mar. Immun Inflamm Dis. 2015. PMID: 27042298 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters